|
|
|
|
Teva says Barr Pharma buyout is complete
Teva Pharmaceutical Industries Ltd.said Tuesday it completed its $7.5 billion buyout of Barr Pharmaceuticals Inc., a rival maker of generic drugs and a major generic oral contraceptive company. Teva agreed to buy Montvale, N.J.-based...
|
|
|
Teva says Barr Pharma buyout is complete
NEW YORK (AP) -- Teva Pharmaceutical Industries Ltd.said Tuesday it completed its $7.5 billion buyout of Barr Pharmaceuticals Inc., a rival maker of generic drugs and a major generic oral contraceptive company. Teva agreed to buy...
|
|
|
Teva says Barr Pharma buyout is complete
NEW YORK - Teva Pharmaceutical Industries Ltd.said Tuesday it completed its $7.5 billion buyout of Barr Pharmaceuticals Inc., a rival maker of generic drugs and a major generic oral contraceptive company. Teva agreed to buy Montvale, N...
|
|
|
Teva says $7.5 billion buyout of oral contraceptive maker Barr Pharmaceuticals is done
Article Tools Smaller| Larger Text Story Tools NEW YORK (AP) - Teva Pharmaceutical Industries Ltd.said Tuesday it completed its $7.5 billion buyout of Barr Pharmaceuticals Inc., a rival maker of generic drugs and a major generic oral...
|
|
|
Strategies for the Pill: Providers share views
When it comes to oral contraceptives (OCs), what is your current practice when it comes to prescribing pills in extended- or continuous- regimens?More providers are prescribing pills in this manner, say respondents to the 2008...
|
|
|
Fitch Affirms Watson Pharmaceuticals' IDR at 'BBB-'; Outlook Stable
CHICAGO--(BUSINESS WIRE)--Fitch has affirmed Watson Pharmaceuticals, Inc.'s (Watson; NYSE: WPI) ratings as follows: --Issuer Default Rating (IDR) at 'BBB-'; --Senior unsecured debt at 'BBB-'; --Bank loan debt at 'BBB-'.The Rating Outlook...
|
